2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
189
Neoplasm Metastasis
24
Neoplasms
23
Ovarian Neoplasms
12
Sarcoma
10
Pancreatic Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Melanoma
7
Endometrial Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Head and Neck Neoplasms
6
Carcinoma, Renal Cell
6
Breast Diseases
6
Recurrence
5
Medulloblastoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Triple Negative Breast Neoplasms
4
Sarcoma, Ewing
4
Neoplasms by Site
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Glioma
4
Glioblastoma
4
Colonic Neoplasms
4
Interventions
Tamoxifen
25
Radiotherapy
15
Chemotherapy, Adjuvant
11
Anastrozole
11
Specimen Handling
10
Neoadjuvant Therapy
8
Letrozole
8
Biopsy
7
Radiation
6
Mastectomy, Segmental
6
Magnetic Resonance Spectroscopy
6
Immunohistochemistry
5
Gene Expression Profiling
5
exemestane
4
Surgical Procedures, Operative
4
Sentinel Lymph Node Biopsy
4
Radiotherapy, Intensity-Modulated
4
Radiotherapy, Conformal
4
Psychiatric Rehabilitation
4
Mass Spectrometry
4
Early Intervention, Educational
4
Counseling
4
afimoxifene
3
Trastuzumab
3
Surveys and Questionnaires
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation Dose Hypofractionation
3
Methods
3
Mastectomy
3
High-Energy Shock Waves
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
palbociclib
×
Clear all
NCT03535506
2025-09-26
WI223281
Georgetown University
Phase 2
Terminated
17 enrolled
9 charts